title: Development of clinical pharmacology as a medical speciality in Europe - the roles of WHO, IUPHAR and EACPT.
abstract: This MiniReview shows that both WHO and IUPHAR very early recognized that there is a gap between the availability of academic expert knowledge in pharmacology and its utilization in health care. Many initiatives have been taken to bridge this gap, but still 12 European countries do not recognize clinical pharmacology as a medical speciality because the profession has failed to develop defined functions in patient care. A first priority for EACPT therefore ought to be to promote clinical pharmacology as a medical speciality recognized by the European Union. The pharmacological services listed in Table 7 that focus on drug problems agree well with those that were recently prioritized in the IUPHAR/WHO/CIOMS manifesto to correct a major weakness in the health care of today in order to promote rational use of drugs.
authors.affiliation: Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Hospital, Huddinge, Stockholm, Sweden.
authors.forename: Folke
authors.initials: F
authors.lastname: Sjöqvist
mesh_terms: D003695:Delivery of Health Care / Q000458:organization & administration*; D005060:Europe; D006801:Humans; D038622:Internationality; D005791:Patient Care / Q000379:methods; D010601:Pharmacology, Clinical / Q000458:organization & administration*; D012958:Societies, Scientific; D013038:Specialization; D014944:World Health Organization